SNV-P-E vs ACAD

Comparison between Synovus Financial Corp (SNV-P-E, Company) and Acadia Pharmaceuticals Inc (ACAD, Company).

5-Year PerformanceSNV-P-E has outperformed ACAD, delivering a return of +6.1% compared to -0.8%

SNV-P-E vs ACAD - Performance Comparison

Log

Key Characteristics

Financial metrics and valuation ratios

Metric	SNV-P-E(COMPANY)	ACAD(COMPANY)
Market Cap	$3.59B	$3.58B
Max Drawdown	63.92%	96.29%
Sharpe Ratio	0.54	-0.01
Industry	Other	Biotechnology
P/E Ratio	4.51	9.48
Forward P/E	N/A	59.17
PEG Ratio	0.04	0.16
5Y Dividends CAGR	7.40%	N/A
5Y EPS CAGR	17.64%	N/A
Debt to Equity	51.70%	0.00%
Free Cash Flow Yield	18.62%	3.17%
P/S Ratio	N/A	3.27
P/B Ratio	N/A	2.81

Market Cap

Winner

SNV-P-E

$3.59B

ACAD

$3.58B

Max Drawdown

Winner

SNV-P-E

63.92%

ACAD

96.29%

Sharpe Ratio

Winner

SNV-P-E

0.54

ACAD

-0.01

Industry

SNV-P-E

Other

ACAD

Biotechnology

P/E Ratio

Winner

SNV-P-E

4.51

ACAD

9.48

Forward P/E

SNV-P-E

N/A

ACAD

59.17

PEG Ratio

Winner

SNV-P-E

0.04

ACAD

0.16

5Y Dividends CAGR

SNV-P-E

7.40%

ACAD

N/A

5Y EPS CAGR

SNV-P-E

17.64%

ACAD

N/A

Debt to Equity

SNV-P-E

51.70%

Winner

ACAD

0.00%

Free Cash Flow Yield

Winner

SNV-P-E

18.62%

ACAD

3.17%

P/S Ratio

SNV-P-E

N/A

ACAD

3.27

P/B Ratio

SNV-P-E

N/A

ACAD

2.81

SNV-P-E vs ACAD - Historical Returns

Returns include dividend reinvestment.

Period	SNV-P-E	ACAD
1 month	+0.31%	-5.13%
3 months	-1.16%	-14.68%
6 months	+4.11%	-10.44%
1 year	+7.94%	-2.09%
5 years(CAGR)	+6.12%	-0.78%
10 years(CAGR)	N/A	-4.73%
Max(CAGR)	+7.05%	+5.36%

Winner

SNV-P-E

+0.31%

ACAD

-5.13%

Winner

SNV-P-E

-1.16%

ACAD

-14.68%

Winner

SNV-P-E

+4.11%

ACAD

-10.44%

Winner

SNV-P-E

+7.94%

ACAD

-2.09%

5Y(CAGR)

Winner

SNV-P-E

+6.12%

ACAD

-0.78%

10Y(CAGR)

SNV-P-E

N/A

ACAD

-4.73%

Max(CAGR)

Winner

SNV-P-E

+7.05%

ACAD

+5.36%

SNV-P-E vs ACAD - Annual Returns (2004 - 2026)

Returns include dividend reinvestment.

Year	SNV-P-E	ACAD
2026	N/A	-19.74%
2025	+6.91%	+43.14%
2024	+18.38%	-40.54%
2023	+13.43%	+91.85%
2022	-14.65%	-34.73%
2021	+6.71%	-55.80%
2020	+6.02%	+30.04%
2019	+8.52%	+156.94%
2018	N/A	-46.86%
2017	N/A	+4.66%
2016	N/A	-16.70%
2015	N/A	+14.45%
2014	N/A	+26.24%
2013	N/A	+428.33%
2012	N/A	+318.92%
2011	N/A	-11.48%
2010	N/A	-11.76%
2009	N/A	+18.92%
2008	N/A	-91.71%
2007	N/A	+26.23%
2006	N/A	-12.01%
2005	N/A	+54.15%
2004	N/A	+1.04%

SNV-P-E vs ACAD Drawdown Comparison

The maximum drawdown for SNV-P-E was -63.32%, occurring on Mar 18, 2020. Recovery took 160 trading sessions.

The maximum drawdown for ACAD was -96.29%, occurring on Nov 12, 2010. Recovery took 1820 trading sessions.

The current SNV-P-E drawdown is -1.75%. The current ACAD drawdown is -62.98%.

Rank	SNV-P-E	ACAD
#1	-63.32% Feb 14, 2020 - Oct 2, 2020	-96.29% Mar 16, 2006 - Jun 10, 2013
#2	-37.79% Sep 16, 2021 - Jan 30, 2024	-77.18% Jul 7, 2020 - Jun 21, 2022
#3	-5.16% Mar 26, 2025 - Jun 12, 2025	-73.99% Jul 17, 2015 - Dec 5, 2019
#4	-4.13% Oct 2, 2025 - Oct 16, 2025	-40.80% Feb 27, 2014 - Dec 2, 2014
#5	-4.07% Dec 21, 2020 - Mar 15, 2021	-38.42% Dec 6, 2019 - Apr 27, 2020
#6	-3.35% Oct 22, 2019 - Dec 16, 2019	-33.81% Mar 10, 2015 - Jul 14, 2015
#7	-3.02% Aug 6, 2021 - Sep 16, 2021	-31.14% Oct 2, 2013 - Feb 25, 2014
#8	-2.96% Oct 2, 2020 - Nov 4, 2020	-25.79% Sep 15, 2004 - Feb 8, 2005
#9	-2.69% Jan 30, 2024 - Feb 15, 2024	-25.26% Jun 17, 2004 - Sep 1, 2004
#10	-2.44% Mar 20, 2024 - May 3, 2024	-23.54% Oct 19, 2005 - Jan 31, 2006
#11	-2.11% Jul 16, 2024 - Aug 29, 2024	-21.59% Feb 9, 2005 - May 24, 2005
#12	-2.09% Dec 16, 2024 - Mar 25, 2025	-14.01% May 20, 2020 - Jun 23, 2020
#13	-2.06% Nov 4, 2020 - Nov 16, 2020	-13.93% Jun 10, 2013 - Jul 15, 2013
#14	-1.95% Apr 13, 2021 - Jun 3, 2021	-13.41% Apr 27, 2020 - May 18, 2020
#15	-1.90% Jul 12, 2021 - Jul 30, 2021	-13.09% Jun 16, 2005 - Jul 20, 2005

Correlation

Correlation between SNV-P-E and ACAD is -0.50 which considered as a moderate negative correlation - the stocks show some tendency to move in opposite directions.

-0.50

-101